BI 705564
Sponsors
Boehringer Ingelheim
Conditions
HealthyLupus Erythematosus, Systemic
Phase 1
This Study in Healthy Men Tests How Different Doses of BI 705564 Are Taken up in the Body and How Well They Are Tolerated. The Study Also Tests How BI 705564 Affects the Way the Body Breaks Down Midazolam
CompletedNCT03325712
Start: 2017-11-17End: 2018-11-26Updated: 2022-09-07
This Study is Done in Healthy Japanese Volunteers. It Looks at How Different Doses of BI 705564 Are Taken up in the Body and How Well They Are Tolerated
WithdrawnNCT03747926
Start: 2019-04-05End: 2019-09-02Updated: 2021-11-15
BI 705564 in Patients With Systemic Lupus Erythematosus (SLE)
WithdrawnNCT03771885
Start: 2019-03-16End: 2020-01-07Updated: 2021-11-15